Department of Medical Laboratory Techniques, Al-Maarif University College, Al-Anbar, Iraq.
Cardiology Department, College of Medicine, Al-Ayen University, Thi-Qar, Iraq.
Cell Biochem Funct. 2024 Apr;42(3):e4006. doi: 10.1002/cbf.4006.
Nuclear paraspeckle assembly transcript 1 (NEAT1) is a long noncoding RNA (lncRNA) that is widely expressed in a variety of mammalian cell types. Altered expression levels of the lncRNA NEAT1 have been reported in liver-related disorders including cancer, fatty liver disease, liver fibrosis, viral hepatitis, and hepatic ischemia. lncRNA NEAT1 mostly acts as a competing endogenous RNA (ceRNA) to sponge various miRNAs (miRs) to regulate different functions. In regard to hepatic cancers, the elevated expression of NEAT1 has been reported to have a relation with the proliferation, migration, angiogenesis, apoptosis, as well as epithelial-mesenchymal transition (EMT) of cancer cells. Furthermore, NEAT1 upregulation has contributed to the pathogenesis of other liver diseases such as fibrosis. In this review, we summarize and discuss the molecular mechanisms by which NEAT1 contributes to liver-related disorders including acute liver failure, nonalcoholic fatty liver disease (NAFLD), liver fibrosis, and liver carcinoma, providing novel insights and introducing NEAT1 as a potential therapeutic target in these diseases.
核旁斑装配转录本 1(NEAT1)是一种广泛表达于多种哺乳动物细胞类型的长链非编码 RNA(lncRNA)。lncRNA NEAT1 的表达水平改变已在与肝脏相关的疾病中被报道,包括癌症、脂肪肝疾病、肝纤维化、病毒性肝炎和肝缺血。lncRNA NEAT1 主要作为竞争性内源性 RNA(ceRNA)来吸附各种 miRNA(miRs),以调节不同的功能。在肝癌方面,有报道称 NEAT1 的高表达与癌细胞的增殖、迁移、血管生成、凋亡以及上皮-间充质转化(EMT)有关。此外,NEAT1 的上调也促成了其他肝脏疾病的发病机制,如纤维化。在这篇综述中,我们总结和讨论了 NEAT1 参与与肝脏相关的疾病(包括急性肝衰竭、非酒精性脂肪性肝病(NAFLD)、肝纤维化和肝癌)的发病机制,为这些疾病提供了新的见解,并将 NEAT1 介绍为一种有潜力的治疗靶点。